5-substituted 2-aryl-4-pyrimidinones

Details 5-substituted 2-aryl-4-pyrimidinones 5-substituted 2-aryl-4-pyrimidinones

2005-09-13

2005-09-13

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S314000, C544S319000

Reexamination Certificate

active

06943173

ABSTRACT:
Arylpyrimidinone compounds that act as selective modulators of CRF 1 receptors are provided. These compounds are useful in the treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided.Compounds of the invention are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.

REFERENCES:
patent: 4665175 (1987-05-01), Maurer
patent: 4686290 (1987-08-01), Maurer
patent: 5254558 (1993-10-01), Bernstein et al.
patent: 5670494 (1997-09-01), Dolle et al.
patent: 5861380 (1999-01-01), Gyorkos et al.
patent: 5948785 (1999-09-01), Akahoshi et al.
patent: 5972946 (1999-10-01), Murata et al.
patent: 6001814 (1999-12-01), Gyorkos et al.
patent: 6121202 (2000-09-01), Karp et al.
patent: 2002/0058667 (2002-05-01), Castelhano et al.
patent: 1122533 (1962-01-01), None
patent: 0 826 671 (1998-03-01), None
patent: 0 826 673 (1998-03-01), None
patent: 0 936 216 (1999-08-01), None
patent: 0 940 400 (1999-09-01), None
patent: 93/21210 (1993-10-01), None
patent: 93/21214 (1993-10-01), None
patent: 95/26958 (1995-10-01), None
patent: 96/39400 (1996-12-01), None
patent: 97/14684 (1997-04-01), None
patent: 99/32459 (1999-07-01), None
patent: 99/36426 (1999-07-01), None
patent: 99/62518 (1999-12-01), None
patent: 99/62538 (1999-12-01), None
Hullar T.L. et al., “Pyridoxal Phosphate. III. Pyrimidine Analogs . . . ” J. Med. Chem,, 1969, vol. 12, No. 3, pp. 424-426.
Dolle et al., “First Examples of Peptidomimetic Inhibitors of Interleukin 1β Converting Enzyme”, J. Med. Chem., vol. 39, pp. 2438-2440, 1996.
Veale et. al., “Nonpeptidic Inhibitors of Human Leukocyte Elastase . . . ”, J. Med. Chem., vol. 38, pp. 98-108, 1995.

Affiliated with

Also associated with

Rating

5-substituted 2-aryl-4-pyrimidinones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-substituted 2-aryl-4-pyrimidinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-substituted 2-aryl-4-pyrimidinones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3385863